[Federal Register Volume 68, Number 1 (Thursday, January 2, 2003)]
[Notices]
[Page 125]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-33138]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 02N-0109]


Agency Information Collection Activities; Announcement of OMB 
Approval; Dissemination of Information on Unapproved/New Uses for 
Marketed Drugs, Biologics, and Devices

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Dissemination of Information on 
Unapproved/New Uses for Marketed Drugs, Biologics, and Devices'' has 
been approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995 (the PRA).

FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Information 
Resources Management (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-1482.

SUPPLEMENTARY INFORMATION: In the Federal Register of September 16, 
2002 (67 FR 58429), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 
section 3507 of the PRA (44 U.S.C. 3507). An agency may not conduct or 
sponsor and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number. 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0390. The approval expires on November 30, 2005. A 
copy of the supporting statement for this information collection is 
available on the Internet at http://www.fda.gov/ohrms/dockets.

    Dated: December 26, 2002.
Margaret M. Dotzel,
Assistant Commissioner for Policy.
[FR Doc. 02-33138 Filed 12-31-02; 8:45 am]
BILLING CODE 4160-01-S